Inventor

WOO BYOUNG YOUNG

KR15 patents

⚠️ This page may combine multiple inventors who share the name “WOO BYOUNG YOUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMOREPACIFIC CORP

13 patents

US7858621B2Dec 28, 2010

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

AMOREPACIFIC CORP25 citations91

US7763657B2Jul 27, 2010

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

AMOREPACIFIC CORP2 citations61

US12059412B2Aug 13, 2024

Pharmaceutical composition containing (R)-N-[1-(3,5-difluoro-4-methanesulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethylpyridin-3-yl)-acrylamide and method for inhibiting crystal formation thereof

AMOREPACIFIC CORP0 citations59

US11992541B2May 28, 2024

Nanoemulsion cosmetic composition and process for preparing same

AMOREPACIFIC CORP0 citations58

US11957669B2Apr 16, 2024

Pharmaceutical composition containing (R)-N-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide

AMOREPACIFIC CORP0 citations58

US11878008B2Jan 23, 2024

Method for preparing (R)-N-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide

AMOREPACIFIC CORP0 citations42

US10696611B2Jun 30, 2020

Adamantane derivative compound

AMOREPACIFIC CORP0 citations39

US10479763B2Nov 19, 2019

Chiral resolution method of N-[4-(1-aminoethyl)-phenyl]-sulfonamide derivatives

AMOREPACIFIC CORP0 citations36

US8013187B2Sep 6, 2011

2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α

AMOREPACIFIC CORP0 citations36

SHIN SONG SEOK

1 patent

US8557872B2Oct 15, 2013

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

SHIN SONG SEOK0 citations34

WOO BYOUNG YOUNG

1 patent

US8691855B2Apr 8, 2014

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same

WOO BYOUNG YOUNG0 citations30

WOO BYOUNG YOUNG

AMOREPACIFIC CORP

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

Pharmaceutical composition containing (R)-N-[1-(3,5-difluoro-4-methanesulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethylpyridin-3-yl)-acrylamide and method for inhibiting crystal formation thereof

Nanoemulsion cosmetic composition and process for preparing same

Pharmaceutical composition containing (R)-N-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide

Composition for preventing or treating atopic dermatitis

Composition for preventing or treating sleep disorders

Composition for hair protection or hair strengthening

Topical sol-gel composition for the treatment of dermatitis

Method for preparing (R)-N-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide

Adamantane derivative compound

Chiral resolution method of N-[4-(1-aminoethyl)-phenyl]-sulfonamide derivatives

2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α

SHIN SONG SEOK

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

WOO BYOUNG YOUNG

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same